VCP ScannerFree US Stock Screener & Financial AnalysisFree US Stock Screener
ScreenerThemes
DCF ValuationCalculate intrinsic value of US stocks
Market ValuationBuffett indicator, CAPE & macro gauges
Total ReturnSee dividends + price return history
DCA CalculatorSimulate recurring buys & compounding
Earnings
FAANG & Tech
AAPL vs MSFTNVDA vs AMDGOOGL vs META
Cloud & Cyber
CRM vs NOWCRWD vs PANWSNOW vs DDOG
Consumer & Auto
TSLA vs FAMZN vs WMTNFLX vs DIS
Finance & Crypto
JPM vs BACV vs MACOIN vs MSTR
Pharma & Energy
LLY vs NVOJNJ vs PFEXOM vs CVX
Compare Any Stocks...
WatchlistInsider
ScreenerThemes
Earnings
WatchlistInsider
WTMWhite Mountains Insurance Group, Ltd.
$2096.56$5.2B
Overview & Verdict
Overview
Valuation & Forecasts
Valuation ModelsEstimatesDCF Model
Price & Analyst Data
Analyst TargetsPrice HistoryTechnical Analysis
Financial Statements
Income StatementBalance SheetCash FlowRatios & Margins
Performance
P/E HistoryRevenue HistoryEarnings HistoryDividend HistoryTotal Return
Ownership
Holders
← Back to Screener
VCP ScannerFree US Stock Screener & Financial Analysis

Find stocks. Verify deeply. Act with conviction.

Data updated daily

Product

  • Screener
  • Themes
  • Valuation
  • Total Return
  • DCA Calculator
  • News
  • Earnings

Resources

  • Market Valuation
  • Compare
  • Insider Activity
  • Methodology
  • How It Works
  • Glossary
  • Learn

Get Ideas

Get weekly stock ideas — free

© 2026 VCP Scanner
AboutPrivacyTerms
Not financial advice. Do your own research.
ScreenerNewsCompareWatchlist
HomeStocksWTMFinancials

White Mountains Insurance Group, Ltd. (WTM) Financials

30Y historyFree accessUpdated daily

Revenue growth remains highly cyclical, characterized by extreme quarterly fluctuations such as the 74.3% expansion in 2025Q2 followed by a 10.8% contraction in 2026Q1.

WTM Income Statement

Income StatementBalance SheetCash FlowRatios
AnnualQuarterly
MetricTTMDec'25Dec'24Dec'23Dec'22Dec'21Dec'20Dec'19Dec'18Dec'17Dec'16Dec'15Dec'14Dec'13Dec'12Dec'11Dec'10Dec'09Dec'08Dec'07Dec'06Dec'05Dec'04Dec'03Dec'02Dec'01Dec'00Dec'99Dec'98Dec'97Dec'96
Revenue2.64B2.71B2.35B2.17B1.16B614.4M895.6M893.4M369.1M373.8M157.7M440M1.41B1.36B2.44B2.17B2.57B4.43B2.96B4.73B4.79B4.63B4.55B3.79B4.21B3.23B851M548M390.3M293.4M363.7M
Revenue Growth %15.76%14.99%8.66%87.12%88.46%-31.4%0.25%142.05%-1.26%137.03%-64.16%-68.82%3.64%-44.1%12.08%-15.33%-42.02%49.76%-37.56%-1.26%3.5%1.73%20.01%-9.84%30.12%280.02%55.29%40.4%33.03%-19.33%63.61%
Medical Costs & Claims1.09B1.25B1.28B1.02B787M581.3M82.3M70.5M33.7M5.2M13.6M14.5M1.03B832.5M1.62B1.58B-1B2.84B3.26B3.18B3.74B03.86B3.11B3.52B3.08B388.8M301.7M229.6M97.1M85.9M
Medical Cost Ratio %41.04%46.28%54.42%46.93%67.97%94.61%9.19%7.89%9.13%1.39%8.62%3.3%73.01%61.14%66.68%72.55%-39.13%64.08%110.26%67.24%77.96%0%84.69%82.05%83.75%95.18%45.69%55.05%58.83%33.09%23.62%
Gross Profit1.56B1.45B1.07B1.15B370.9M33.1M813.3M822.9M335.4M368.6M144.1M425.5M380.9M529.1M811.6M596.6M3.57B1.59B-303.2M1.55B1.06B4.63B697.1M681M683.7M155.8M462.2M246.3M160.7M196.3M277.8M
Gross Margin %58.96%53.72%45.58%53.07%32.03%5.39%90.81%92.11%90.87%98.61%91.38%96.7%26.99%38.86%33.32%27.45%139.13%35.92%-10.26%32.76%22.04%100%15.31%17.95%16.25%4.82%54.31%44.95%41.17%66.91%76.38%
Gross Profit Growth %-35.55%-6.68%210%1020.54%-95.93%-1.17%145.35%-9.01%155.79%-66.13%11.71%-28.01%-34.81%36.04%-83.29%124.58%624.44%-119.55%46.74%-77.18%564.45%2.36%-0.39%338.83%-66.29%87.66%53.27%-18.14%-29.34%29.75%
Operating Expenses328.6M125.7M756.3M584.4M520.3M306.7M152.9M417.8M513.6M360.8M291.4M296.3M410.3M370.5M548.8M498.6M203.7M826.1M835.2M869.3M327M4.63B449.3M307M564.7M-2.93B104.2M116.3M81.1M-41M51.7M
OpEx / Revenue %12.42%4.64%32.12%26.97%44.93%49.92%17.07%46.77%139.15%96.52%184.78%67.34%29.08%27.21%22.53%22.94%7.94%18.66%28.26%18.36%6.82%100%9.87%8.09%13.42%-90.71%12.24%21.22%20.78%-13.97%14.22%
Depreciation & Amortization6.3M2.6M-6.4M-17.8M4.3M21.6M9.6M29.8M25.7M22.4M20.4M3.8M35.3M28.6M50.8M0-36.2M0000-12.2M000-91.6M-41.4M-11.8M-2.7M67.1M92.8M
Combined Ratio %53.47%50.92%86.55%73.91%112.9%144.53%26.26%54.66%148.28%97.91%193.41%70.64%102.08%88.35%89.21%95.49%-31.2%82.74%138.52%85.6%84.78%100%94.56%90.14%97.17%4.47%57.93%76.28%79.61%19.12%37.83%
Operating Income1.23B1.33B316.7M565.4M-149.4M-273.6M660.4M405.1M-178.2M7.8M-147.3M129.2M-29.4M158.6M262.8M98M164.7M764M-1.14B681.5M729.8M444.7M247.8M374M119M3.09B358M130M79.6M237.3M226.1M
Operating Margin %46.53%49.08%13.45%26.09%-12.9%-44.53%73.74%45.34%-48.28%2.09%-93.41%29.36%-2.08%11.65%10.79%4.51%6.42%17.26%-38.52%14.4%15.22%9.6%5.44%9.86%2.83%95.53%42.07%23.72%20.39%80.88%62.17%
Operating Income Growth %-319.55%-43.99%478.45%45.39%-141.43%63.02%327.33%-2384.62%105.3%-214.01%539.46%-118.54%-39.65%168.16%-40.5%-78.44%167.11%-267.04%-6.62%64.11%79.46%-33.74%214.29%-96.15%762.93%175.38%63.32%-66.46%4.95%542.33%
EBITDA1.26B1.33B310.3M547.6M-145.1M-252M670M434.9M-152.5M30.2M-126.9M133M5.9M187.2M313.6M153.2M128.5M834.8M-1.02B819.9M779.9M432.5M296.9M420.9M190.8M3B316.6M118.2M76.9M304.4M318.9M
EBITDA Margin %47.61%49.17%13.18%25.27%-12.53%-41.02%74.81%48.68%-41.32%8.08%-80.47%30.23%0.42%13.75%12.88%7.05%5.01%18.86%-34.61%17.32%16.27%9.34%6.52%11.09%4.53%92.69%37.2%21.57%19.7%103.75%87.68%
Interest Expense60.3M58.8M60.8M62.7M40.3M20.5M7.4M17.6M9.5M2.3M3M1.6M14.2M16.2M44.8M55.2M57.3M70.8M115.5M138.4M50.1M96.9M49.1M48.6M71.8M45.7M16.1M14.7M13.7M10.6M46.3M
Non-Operating Income-79.9M-78.4M-60.8M-62.7M-40.3M-20.5M-7.4M-17.6M-9.5M-2.3M-3M-1.6M-14.2M-16.2M-44.8M-55.2M-81.9M-70.8M-115.5M-138.4M-50.1M42.6M-49.1M-46.9M-71.8M3.04B-16.1M-14.7M-13.7M226.7M179.8M
Pretax Income1.23B1.33B316.7M565.4M-149.4M-273.6M660.4M405.1M-178.2M7.8M-147.3M129.2M-29.4M158.6M262.8M98M189.3M764M-1.14B681.5M729.8M293M247.8M374M119M-450.2M358M130M79.6M101.3M27.5M
Pretax Margin %46.53%49.08%13.45%26.09%-12.9%-44.53%73.74%45.34%-48.28%2.09%-93.41%29.36%-2.08%11.65%10.79%4.51%7.38%17.26%-38.52%14.4%15.22%6.33%5.44%9.86%2.83%-13.92%42.07%23.72%20.39%34.53%7.56%
Income Tax118.1M126.9M32.6M-15.5M41.4M44.4M-14.8M29.3M-4M-7.8M-32.9M-12.7M-14.8M32.6M-15.7M-110M20.9M208.8M-498.7M210.5M98.9M36.5M47M127M11.7M-179.2M43M42M28.5M36.4M18.9M
Effective Tax Rate %9.6%9.55%10.29%-2.74%-27.71%-16.23%-2.24%7.23%2.24%-100%22.34%-9.83%50.34%20.55%-5.97%-112.24%11.04%27.33%43.81%30.89%13.55%12.46%18.97%33.96%9.83%39.8%12.01%32.31%35.8%35.93%68.73%
Net Income1.04B1.11B230.4M509.2M792.8M-275.4M708.7M414.5M-141.2M627.2M401.8M295.2M312.2M321.6M207.4M767.9M86.5M470M-555.3M407.4M673.2M290.1M418.7M281M2.07B-259M408M121M78.5M39.3M8.6M
Net Margin %39.37%40.87%9.79%23.5%68.47%-44.82%79.13%46.4%-38.26%167.79%254.79%67.09%22.12%23.62%8.52%35.34%3.37%10.62%-18.79%8.61%14.04%6.26%9.2%7.41%49.1%-8.01%47.94%22.08%20.11%13.39%2.36%
Net Income Growth %3632.62%380.21%-54.75%-35.77%387.87%-138.86%70.98%393.56%-122.51%56.1%36.11%-5.45%-2.92%55.06%-72.99%787.75%-81.6%184.64%-236.3%-39.48%132.06%-30.71%49%-86.4%897.72%-163.48%237.19%54.14%99.75%356.98%-89.77%
EPS (Diluted)407.73430.1489.79198.63276.96-89.46227.72130.27-41.76146.0682.1950.6051.2151.8930.509.2610.1253.10-54.5437.8962.3226.5639.9223.6380.75-41.9352.8420.3511.945.400.60
EPS Growth %3453.85%379.05%-54.8%-28.28%409.59%-139.29%74.81%411.95%-128.59%77.71%62.43%-1.19%-1.31%70.13%229.37%-8.5%-80.94%197.36%-243.94%-39.2%134.64%-33.47%68.94%-70.74%292.58%-179.35%159.66%70.44%121.11%800%-93.45%
EPS (Basic)-430.1489.79198.63276.96-89.46227.72130.27-41.76146.0682.2450.6051.2151.8930.509.2610.1253.11-54.5437.9662.5126.9642.2826.4888.61-41.9353.0820.3513.385.980.66
Diluted Shares Outstanding2.55M2.55M2.53M2.53M2.83M3.04M3.08M3.14M3.34M4.29M5.02M5.88M6.03M6.2M6.8M7.58M8.55M8.85M10.18M10.75M10.8M10.79M10.47M10.61M9.05M6.18M5.91M6.15M6.57M7.28M8.17M

Key Metrics

Growth RegimeMixed
ProfitabilityStrained
Balance SheetFortress
Cash FlowMixed
Top Statement Risk

Underwriting Volatility and Cyclicality

Verified Source

Metrics are mathematically derived from official filings.

SEC 10-K (2026Q1)

Underwriting Profitability Exhibits Significant Volatility

As evidenced by the quarterly data, WTM's combined ratio has fluctuated wildly, ranging from a negative 56.4% in 2025Q4 to a concerning 133.7% in 2024Q4, suggesting that the firm's underwriting performance remains highly sensitive to episodic catastrophe events and potential reserve adjustments within its Ark segment.

The extreme variance in the combined ratio indicates that WTM's underwriting engine lacks the consistent margin stability seen in more diversified peers. Investors should monitor whether the recent 2026Q1 combined ratio of 104.9% represents a structural shift toward underwriting losses or merely a temporary impact from specific loss events.

Revenue Growth Remains Highly Cyclical

Based on the reported financial statements, WTM's top-line trajectory shows significant inconsistency, with quarterly revenue growth swinging from a 51.4% contraction in 2024Q4 to a 74.3% expansion in 2025Q2, reflecting the inherent volatility of its reinsurance-heavy business model and the timing of large-scale underwriting transactions.

The erratic revenue patterns suggest that WTM's growth is less a function of steady premium accumulation and more dependent on the timing of major contract renewals and market-wide pricing cycles. This lack of predictability complicates long-term valuation, as the firm's revenue base appears susceptible to sharp, event-driven shifts.

Pristine Balance Sheet Lacks Deployment

According to recent financial disclosures, WTM maintains an exceptionally low debt-to-equity ratio of 0.13%, which, while providing a fortress-like balance sheet, may indicate that the company is currently under-leveraged and failing to deploy its excess capital efficiently to drive meaningful, sustainable earnings growth for shareholders.

While a low debt profile offers significant downside protection, it also suggests that WTM may be holding substantial idle capital that is not contributing to ROIC. This capital position warrants further investigation into whether management is waiting for a specific market dislocation or if they are struggling to identify accretive deployment opportunities.

Earnings Quality Masked by Volatility

As reported in quarterly filings, the company's net income is frequently distorted by non-operating items, such as the 2025Q4 net income of $835.8M, which appears disconnected from core underwriting performance and suggests that headline earnings may not accurately reflect the underlying health of the insurance operations.

The reliance on non-recurring gains to bolster net income may obscure the true economic performance of the Ark and NSM segments. Analysts should be cautious in extrapolating these high-margin periods, as they appear to be driven by idiosyncratic events rather than a repeatable, scalable underwriting or fee-based strategy.

WTM — Frequently Asked Questions

Quick answers to the most common questions about buying WTM stock.

What was White Mountains Insurance Group, Ltd.'s (WTM) revenue in 2025?

For fiscal year 2025, White Mountains Insurance Group, Ltd. (WTM) reported total revenue of $2.71B. This represents a 644.4% increase compared to $363.7M in 1996.

Is White Mountains Insurance Group, Ltd. (WTM) profitable?

White Mountains Insurance Group, Ltd. (WTM) is profitable, generating $1.11B in net income for the fiscal year ending 2025 with a net profit margin of 40.9%.

What is White Mountains Insurance Group, Ltd.'s operating profit margin?

White Mountains Insurance Group, Ltd. (WTM) reported an operating income of $1.33B, resulting in an operating profit margin of 49.1%. This margin reflects the operational efficiency of the business before interest and taxes.

What is White Mountains Insurance Group, Ltd.'s gross profit and gross margin?

White Mountains Insurance Group, Ltd. (WTM) generated $1.45B in gross profit for the year, representing a gross profit margin of 53.7%. This demonstrates the company's core pricing power and production efficiency.